Hélène Mouly

558 total citations
14 papers, 475 citations indexed

About

Hélène Mouly is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Hélène Mouly has authored 14 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Hélène Mouly's work include Renal and related cancers (5 papers), Eosinophilic Disorders and Syndromes (3 papers) and Cancer-related Molecular Pathways (3 papers). Hélène Mouly is often cited by papers focused on Renal and related cancers (5 papers), Eosinophilic Disorders and Syndromes (3 papers) and Cancer-related Molecular Pathways (3 papers). Hélène Mouly collaborates with scholars based in France, United Kingdom and United States. Hélène Mouly's co-authors include Christian Bréchot, Michael C. Kew, C. Giannini, Patrizia Paterlini-Bréchot, C. Bréchot, Hong Tu, Dina Kremsdorf, Patrick Soussan, Celestino Bonura and C Nézelof and has published in prestigious journals such as Oncogene, The FASEB Journal and FEBS Letters.

In The Last Decade

Hélène Mouly

14 papers receiving 468 citations

Peers

Hélène Mouly
Abelev Gi Russia
Colby A. Wyatt United States
Marcy Clayton United States
Viveka Björklund Netherlands
Rajeev K. Boregowda United States
Hélène Mouly
Citations per year, relative to Hélène Mouly Hélène Mouly (= 1×) peers Toshifumi Kuroda

Countries citing papers authored by Hélène Mouly

Since Specialization
Citations

This map shows the geographic impact of Hélène Mouly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Mouly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Mouly more than expected).

Fields of papers citing papers by Hélène Mouly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Mouly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Mouly. The network helps show where Hélène Mouly may publish in the future.

Co-authorship network of co-authors of Hélène Mouly

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Mouly. A scholar is included among the top collaborators of Hélène Mouly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Mouly. Hélène Mouly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Simon, Marie‐Thérèse, Alain Pauloin, Guillaume Normand, et al.. (2003). HIP/PAP stimulates liver regeneration after partial hepatectomy and combines mitogenic and anti‐apoptotic functions through the PKA signaling pathway. The FASEB Journal. 17(11). 1441–1450. 69 indexed citations
2.
Faivre, J, Marie Frank-Vaillant, Robert Poulhe, et al.. (2002). Centrosome overduplication, increased ploidy and transformation in cells expressing endoplasmic reticulum-associated cyclin A2. Oncogene. 21(10). 1493–1500. 27 indexed citations
3.
Faivre, J, Marie Frank-Vaillant, Robert Poulhe, et al.. (2001). Membrane‐anchored cyclin A2 triggers Cdc2 activation in Xenopus oocyte. FEBS Letters. 506(3). 243–248. 5 indexed citations
4.
Tu, Hong, Celestino Bonura, C. Giannini, et al.. (2001). Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.. PubMed. 61(21). 7803–10. 161 indexed citations
5.
Berasain, Carmen, et al.. (1998). Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon Hepatitis B virus genome insertion. Oncogene. 16(10). 1277–1288. 36 indexed citations
6.
Rosenberg, Arielle R., Frédérique Zindy, Françoise Le Deist, et al.. (1995). Overexpression of human cyclin A advances entry into S phase.. PubMed. 10(8). 1501–9. 78 indexed citations
7.
Barbey, S, et al.. (1990). Del cell line: A “malignant histiocytosis” CD30 + T(5;6)(Q35;P21) cell line. International Journal of Cancer. 45(3). 546–553. 18 indexed citations
8.
Droz, D, et al.. (1990). Cell differentiation in Wilms' tumor (nephroblastoma): An immunohistochemical study. Human Pathology. 21(5). 536–544. 41 indexed citations
9.
Rousseau-Merck, Marie-Françoise, et al.. (1986). Cytogenetic study of cell lines from an infantile hypercalcemic renal tumor. Cancer Genetics and Cytogenetics. 21(2). 117–122. 2 indexed citations
10.
Rousseau-Merck, Marie-Françoise, et al.. (1986). Cytogenetic study of malignant histiocytosis transplanted into nude mice; presence of translocation between chromosomes 5 and 6 and a unique marker (13q+). Virchows Archiv B Cell Pathology Including Molecular Pathology. 50(1). 339–344. 17 indexed citations
11.
Rousseau-Merck, M.F., et al.. (1985). Transplantability in nude mice of embryonic and other childhood tumours. British Journal of Cancer. 52(2). 279–283. 7 indexed citations
12.
Rousseau-Merck, M.F., et al.. (1985). Bilateral nephroblastoma associated with a 3;17 translocation. Cytogenetic and Genome Research. 39(1). 64–66. 4 indexed citations
13.
Rousseau-Merck, M.F., S Barbey, Hélène Mouly, S Bazin, & C Nézelof. (1979). Collagenolytic activity of eosinophilic granuloma in vitro. Cellular and Molecular Life Sciences. 35(9). 1226–1228. 5 indexed citations
14.
Rousseau-Merck, M.F., Marie‐Christine Lombard, C Nézelof, & Hélène Mouly. (1977). Limitation of the potentialities of nephroblastoma differentiation in vitro. European Journal of Cancer (1965). 13(2). 163–170. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026